The main aims of Genetracer Biotech are to develop different activities in health and biotechnology research & development. Genetracer Biotech’s know-how comes from its founders’ knowledge and experience gained through previous research work in pharmacogenomics, with a particular focus on genomics that have an important influence on cholinergic activity and metabolism and nicotinic receptors in the central nervous System. These results have now been patented: WO2013/156658 A1 and WO2013/156657 A1.